Inhibitory effect of matrine on the expression of PSA and AR in prostate cancer cell line LNCaP

Abstract

In order to investigate the inhibitory effect of matrine on the expression of prostate specific antigen (PSA) and androgen receptor (AR) in prostate cancer cell line LNCaP in vitro, LNCaP cells were treated with matrine at different concentrations (0.5, 1.0, 1.5, 2.0 g/L) for 12–36 h. The growth activities of cancer cells were determined by MTT colorimetric assay. The AR level was measured by Western blotting. The expression of PSA was detected by using AXSYM system-chemical luciferase methods. The results showed that matrine could effectively inhibit the growth of androgen-dependent prostate cancer cell line LNCaP in vitro in a time- and dose-dependent manner (P<0.05). It could obviously decrease the level of AR (P<0.01) and inhibit the expression of PSA in a dose-dependent manner (P<0.05) in LNCaP cells. It was concluded that matrine could significantly suppress the growth of LNCaP cells and inhibit the expression of PSA and AR of prostate cancer cells.

Keywords

prostate cancer / matrine / LNCaP cells / androgen receptor / prostate specific antigen

References

[1] OhmiyaS.. Stereochemistry, syntheses and biological activity of lupine alkaloids—from studies on the leguminous plants growing mainly in Japan. Yakugaku Zasshi, 2007, 127(10): 1557-1577

[2] ZhangM. J., HuangJ.. Recent research progress of anti-tumor machnism of matrine. Zhongguo Zhong Yao Za Zhi (Chinese), 2004, 29(2): 115-118

[3] ShrikhandeS. V., KleeffJ., KayedH., et al.. Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells. Anticancer Res, 2006, 26(5): 3265-3273

[4] Kemény-BekeA., BerényiE., FacskóA., et al.. Antiproliferative effect of 4-thiouridylate on OCM-1 uveal melanoma cells. Eur J Ophthalmol, 2006, 16(5): 680-685

[5] KoY. J., DeviG. R., LondonC. A., et al.. Androgen receptor down-regulation in prostate cancer with phosphorodiamidate morpholino antisense oligomers. J Urol, 2004, 172(3): 1140-1144

[6] YangL., ZhangL. Y., ChenW. W., et al.. Inhibition of the expression of prostate specific antigen by curcumin. Yao Xue Xue Bao (Chinese), 2005, 40(9): 800-803

[7] HoqueA., ChenH., XuX. C.. Statin induces apoptosis and cell growth arrest in prostate cancer cells. Cancer Epidemiol Biomarkers Prev, 2008, 17(1): 88-94

[8] AlbertiC.. Prostate cancer progression and surrounding microenvironment. Int J Biol Markers, 2006, 21(2): 88-95

[9] IeroM., PillaL., MarrariA., et al.. Vaccination therapy in prostate cancer. Cancer Immunol Immunother, 2007, 56(4): 429-445

[10] RichterE., SrivastavaS., DobiA.. Androgen receptor and prostate cancer. Prostate Cancer Prostatic Dis, 2007, 10(2): 114-118

[11] AgoulnikI. U., WeigelN. L.. Androgen receptor action in hormone-dependent and recurrent prostate cancer. J Cell Biochem, 2006, 99(2): 362-372

[12] KageyamaY., HyochiN., KiharaK., et al.. The androgen receptor as putative therapeutic target in hormone-refractory prostate cancer. Recent Patents Anticancer Drug Discov, 2007, 2(3): 203-211

[13] ChmelarR., BuchananG., NeedE. F., et al.. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer, 2007, 120(4): 719-733

[14] SinghP., UzgareA., LitvinovI., et al.. Combinatorial androgen receptor targeted therapy for prostate cancer. Endocr Relat Cancer, 2006, 13(3): 653-666

[15] RossJ. S.. The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test. Adv Anat Pathol, 2007, 14(5): 353-357

[16] FournierG., ValeriA., ManginP., et al.. Prostate cancer: Diagnosis and staging. Ann Urol, 2004, 38(5): 207-224

[17] WiwanitkitV.. Prostate specific antigen for screening for prostate cancer: an appraisal of Thai reports. Asian Pac J Cancer Prev, 2004, 5(4): 406-408

[18] KimJ., CoetzeeG. A.. Prostate specific antigen gene regulation by androgen receptor. J Cell Biochem, 2004, 93(2): 233-241

[19] TaplinM. E., BalkS. P.. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem, 2004, 91(3): 483-490

[20] MaL. D., ZhangY., WenS. H., et al.. Inhibition of tumor growth in tumor-bearing mice treated with matrine. Zhonghua Zhong Liu Za Zhi (Chinese), 2005, 27(6): 339-341